Senseonics: Eversense 365 Receives FDA Clearance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/6/2026

1. MRVL
2. USO
3. SPY
4. BBIO
5. NVDA
6. OPCH
7. GOOGL
8. AMD
9. CHRW
10. NEOG

Go back to Senseonics: Eversense 365 Receives FDA Clearance

Eversense 365 Receives FDA Clearance: The World’s First One Year CGM

September 17, 2024 7:00 AM EDT

Eversense 365 cleared in the U.S. as an integrated continuous glucose monitoring (iCGM) system for people with diabetes

With a single sensor, the Eversense 365 system provides one year of use, versus 10-14 days with short-term CGMs for minimal life disruption

Launch expected early in the fourth quarter of 2024

GERMANTOWN, Md. & PARSIPPANY, N.J.--(BUSINESS WIRE)-- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose... More